Generic and innovative drugs market in CIS countries 2013 Russia Ukraine and Kazakhstan

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Arterium Corporation (GFARM) - Financial and Strategic SWOT Analysis Review

Arterium Corporation (GFARM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

Summary Arterium Corporation (Arterium) is a pharmaceutical company. The company develops, manufactures and markets pharmaceuticals, and antibacterial and herbal based medications. Its products include acelysin, acetylsalicylic acid, alteyca galychpharm, ambroxol, kanamycin, nicergolin, nifuroxazide, ...

Industries: Drug and Medication | Countries: Ukraine, Uzbekistan, Kazakhstan, Azerbaijan, Russian Federation, Belarus

Veropharm (VRPH) - Financial and Strategic SWOT Analysis Review

Veropharm (VRPH) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

Summary Veropharm is a pharmaceutical company. The company develops and manufactures generic pharmaceutical drugs, oncological medications, and medical adhesive bandages. It operates through three plants, such as Voronezh Chemical-Pharmaceutical Plant, Belgorod and Basil plant, and Pokrov ready-made ...

Industries: Drug and Medication | Countries: Russian Federation

Genexine, Inc. (095700) - Financial and Strategic SWOT Analysis Review

Genexine, Inc. (095700) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

Summary Genexine, Inc. (Genexine) is a biotechnology company. The company develops and conducts research on therapeutic vaccines for incurable diseases and next-generation antibody fusion protein drugs such as super-biosimilars. Its products include GX-E2 for Anemia, GX-G6 for Diabetes, GX-H9 for Dwarfism, ...

Industries: Drug and Medication | Countries: Brazil, Russian Federation, Thailand, South Korea, India

Russia Pharmaceuticals and Healthcare Report Q4 2104

Russia Pharmaceuticals and Healthcare Report Q4 2104

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • October 2014
  • 112 pages

Includes 3 FREE quarterly updates BMI View: Russia's cooling of relations with the West is putting pressure on foreign investment in the country. With the EU and the US applying further sanctions, the business environment in the country is deteriorating. As the government pushes through protectionist ...

Industries: Drug and Medication | Countries: Russian Federation

Russia Hyperbaric Oxygen Chambers Market Outlook to 2020

Russia Hyperbaric Oxygen Chambers Market Outlook to 2020

  • $ 2 500
  • Industry report
  • by Global Data
  • October 2014
  • 27 pages

Russia Hyperbaric Oxygen Chambers Market Outlook to 2020 Summary GlobalData's new report, "Russia Hyperbaric Oxygen Chambers Market Outlook to 2020", provides key market data on the Russia Hyperbaric Oxygen Chambers market. The report provides value, in millions of US dollars, volume (in units) and average ...

Industries: Drug and Medication | Countries: Russian Federation

Russia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Russia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • June 2014
  • 112 pages

Includes 3 FREE quarterly updates BMI View: The Russian pharmaceutical industry retains vast growth potential and the short- term environment is very positive for both domestic and foreign drugmakers. WTO accession will be an important stimulus for enforcing intellectual property (IP) rights. The economy ...

Industries: Drug and Medication | Countries: Russian Federation

Russia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Russia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • March 2014
  • 110 pages

Includes 3 FREE quarterly updates BMI View: On the positive side, Russia’s pharmaceutical industry should regain double-digit US dollar growth from 2013 and the approval of the country’s entry to the WTO should provide a clearer regulatory pathway for foreign original drugmakers through strong intellectual ...

Industries: Drug and Medication | Countries: Russian Federation

MarketVIEW: Rabies vaccines

MarketVIEW: Rabies vaccines

  • $ 4 495
  • Industry report
  • by VacZine Analytics Group Of Assay Advantage Ltd
  • March 2014
  • 67 pages

Rabies is a viral zoonosis caused by all members of the Lyssavirus genus and mostly spread by canine vectors. The disease, if untreated is 100% fatal, although almost 100% preventable through timely postexposure prophylaxis (PEP). Rabies causes tens of thousands of deaths each year, mainly in rural areas ...

Industries: Drug and Medication | Countries: China, World, Asia, India, Africa, South Africa, Brazil, Canada, Vietnam, Thailand, Philippines, United States, Europe, Sri Lanka, Indonesia, Bangladesh, Russian Federation, Nepal, Myanmar, Cambodia

Russia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Russia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • December 2013
  • 115 pages

BMI View: Renewed liberalisation of Russia’s pharmaceutical industry could follow the final approval of the country’s membership of the World Trade Organisation (WTO) at the end of 2011. Liberalisation in terms of industry entry and increased intellectual property (IP) protection (illiberal in the ...

Industries: Drug and Medication | Countries: Russian Federation

Russian Pharmaceutical Market Outlook to 2017

Russian Pharmaceutical Market Outlook to 2017

  • $ 800
  • Industry report
  • by RNCOS
  • December 2013
  • 80 pages

The pharmaceutical industry in Russia finally seems ready for a change. With the government adopting ‘Strategy 2020' to improve the production capacity of the Russian pharma sector, pharmaceutical companies have started investing in the Russian market. As a result, the Russian pharmaceutical industry ...

Industries: Drug and Medication | Countries: Russian Federation

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.